Both in Biotechnology
Odyssey Therapeutics vs Ginkgo Bioworks Holdings
Over the past year ODTX returned −20.7% and DNA returned +66.1%; their daily moves had a correlation of 0.39.
ODTX −20.7% DNA +66.1%Growth of $1, one year, split-adjusted
| Metric | ODTX | DNA |
|---|---|---|
| Price | $19.54 | $11.21 |
| Market cap | $939.1M | $754.9M |
| Today | −1.46% | −12.01% |
| 1 month | −4.3% | −10.3% |
| 6 months | — | +15.6% |
| Year to date | — | +34.9% |
| 1 year | — | −8.0% |
| Revenue growth (YoY) | — | −48.5% |
| Gross margin | — | 91.5% |
| Net margin | — | −231.7% |
| P/E (TTM) | — | — |
| Price / sales | — | 6.7× |
| Net cash | $310.6M | $302.2M |
| Dividend yield | — | — |
| Volatility (60d) | — | 125.2% |
| Short % of float | 13.6% | 18.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).